The Effect of Flutamide on Ovulation Induction in PCOS Patients
暂无分享,去创建一个
[1] V. Tse,et al. The Female Patient , 2013 .
[2] S. Domino,et al. Contemporary medical therapy for polycystic ovary syndrome , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[3] M. Hill,et al. Flutamide Suppresses Adrenal Steroidogenesis but Has No Effect on Insulin Resistance and Secretion and Lipid Levels in Overweight Women with Polycystic Ovary Syndrome , 2004, Gynecologic and Obstetric Investigation.
[4] F. de Zegher,et al. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. , 2004, The Journal of clinical endocrinology and metabolism.
[5] U. Pagotto,et al. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome , 2004, Clinical endocrinology.
[6] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[7] M. Ferin,et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. , 2003, The Journal of clinical endocrinology and metabolism.
[8] F. de Zegher,et al. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome. , 2003, Human reproduction.
[9] A. Paoletti,et al. The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. , 2002, Fertility and sterility.
[10] Richard S Legro,et al. Polycystic ovary syndrome: the new millenium , 2001, Molecular and Cellular Endocrinology.
[11] E. Diamanti-Kandarakis,et al. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.
[12] G. Morgante,et al. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF) , 1998, Clinical endocrinology.
[13] G. Morgante,et al. Hormonal effects of flutamide in young women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.